TY -的T1是世卫组织新extens的定义ively drug-resistant tuberculosis easy to apply in practice? JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.00959-2021 VL - 58 IS - 1 SP - 2100959 AU - Alagna, Riccardo AU - Cabibbe, Andrea Maurizio AU - Miotto, Paolo AU - Saluzzo, Francesca AU - Köser, Claudio Umberto AU - Niemann, Stefan AU - Gagneux, Sebastien AU - Rodrigues, Camilla AU - Rancoita, Paola Vittoria Maria AU - Cirillo, Daniela Maria Y1 - 2021/07/01 UR - //www.qdcxjkg.com/content/58/1/2100959.abstract N2 - The World Health Organization (WHO) recently endorsed a new definition of extensively drug-resistant tuberculosis (XDR-TB) and, for the first time, introduced the category of pre-XDR-TB [1]. Pre-XDR-TB is defined as multidrug resistance/rifampicin resistance (MDR/RR) in conjunction with resistance to any fluoroquinolone (levofloxacin or moxifloxacin), whereas the conditions for XDR-TB are now met by additional resistance to a group A drug (bedaquiline or linezolid) [1].The new definition of extensively drug resistant tuberculosis endorsed by WHO poses some challenges that must be addressed in a coordinated fashion by researchers, TB control stakeholders and assay developers https://bit.ly/3eAMU8B ER -